L. Howard (London, United Kingdom), P. Escribano-Subias (Madrid, Spain)
Thoracic CT features of patients with BMPR2 mutation: preliminary analysis from the UK National Cohort Study of Idiopathic and Heritable PAH
M. Cogliano (Sheffield, United Kingdom), A. Lawrie (Sheffield, United Kingdom), D. Kiely (Sheffield, United Kingdom), R. Condliffe (Sheffield, United Kingdom), S. Rajaram (Sheffield, United Kingdom), N. Screaton (Papworth, United Kingdom), C. Hadinnapola (Cambridge, United Kingdom), E. Swietlik (Cambridge, United Kingdom), S. Gräf (Cambridge, United Kingdom), L. Howard (London, United Kingdom), G. Coghlan (London, United Kingdom), S. Wort (London, United Kingdom), J. Pepke-Zaba (Papworth, United Kingdom), J. Lordan (Newcastle, United Kingdom), M. Johnson (Glasgow, United Kingdom), M. Wilkins (London, United Kingdom), N. Morrell (Cambridge, United Kingdom), A. Swift (Sheffield, United Kingdom)
|  |
Pulmonary vascular disease (PVD) in patients with Sjögren syndrome - a prospective cross-sectional study
P. Douschan (Graz, Austria), J. Horwath-Winter (Graz, Austria), J. Hermann (Graz, Austria), M. Stradner (Graz, Austria), T. Sassmann (Graz, Austria), V. Foris (Graz, Austria), A. Avian (Graz, Austria), H. Olschewski (Graz, Austria), G. Kovacs (Graz, Austria)
| |
Pulmonary hypertension associated with neurofibromatosis type 1: data from the French Pulmonary Hypertension Registry
E. Jutant (Le Kremlin Bicêtre, France), X. Jaïs (Le Kremlin Bicêtre, France), B. Girerd (Paris, France), X. Mignard (Le Kremlin Bicêtre, France), M. Ghigna (Le Plessis Robinson, France), D. Bourlier (Bordeaux, France), C. Tromeur (Brest, France), E. Bergot (Caen, France), G. Prévot (Toulouse, France), C. Dauphin (Clermont Ferrand, France), N. Favrolt (Dijon, France), J. Traclet (Lyon, France), P. Moceri (Nice, France), T. Soumagne (Besançon, France), F. Bauer (Rouen, France), P. Degroote (Lille, France), C. Chabanne (Rennes, France), P. Magro (Tours, France), L. Bertoletti (Saint Etienne, France), L. Savale (Le Kremlin Bicêtre, France), F. Soubrier (Paris, France), G. Simonneau (Le Kremlin Bicêtre, France), O. Sitbon (Le Kremlin Bicêtre, France), P. Brillet (Bobigny, France), M. Humbert (Le Kremlin Bicêtre, France), D. Montani (Le Kremlin Bicêtre, France)
| |
Macitentan in portopulmonary hypertension (PoPH): Real-world data from OPUS and OrPHeUS
N. Kim (La Jolla, United States of America), K. Chin (Dallas, United States of America), V. Mclaughlin (Ann Arbor, United States of America), R. Restrepo-Jaramillo (Tampa, United States of America), Z. Safdar (Houston, United States of America), M. Brand (Allschwil, Switzerland), M. Flynn (South San Francisco, United States of America), S. Leroy (Allschwil, Switzerland), A. Morganti (Allschwil, Switzerland), R. Channick (Los Angeles, United States of America)
|  |
Macitentan in pulmonary hypertension (PH): Data from OPUS and OrPHeUS real-world data sets
N. Kim (La Jolla, United States of America), R. Channick (Los Angeles, United States of America), K. Chin (Dallas, United States of America), L. Melendres-Groves ( Albuquerque, United States of America), A. Ravichandran ( Indianapolis, United States of America), M. Brand ( Allschwil, Switzerland), M. Flynn (South San Francisco, United States of America), S. Leroy ( Allschwil, Switzerland), A. Morganti ( Allschwil, Switzerland), V. Mclaughlin ( Ann Arbor, United States of America)
| |
Diagnostic accuracy of right ventricular trabecular mass measurements as measured on cardiac MRI in suspected pulmonary hypertension
A. Macdonald (Sheffield, United Kingdom), C. Johns (Sheffield, United Kingdom), P. Garg (Sheffield, United Kingdom), M. Cogliano (Sheffield, United Kingdom), R. Condliffe (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom), D. Kiely (Sheffield, United Kingdom), A. Swift (Sheffield, United Kingdom)
| |
Diagnostic and prognostic value of a diagnostic CT regression model in suspected pulmonary hypertension
A. Swift (Sheffield, United Kingdom), C. Johns (Sheffield, United Kingdom), M. Chin (Sheffield, United Kingdom), B. Currie (Sheffield, United Kingdom), C. Elliot (Sheffield, United Kingdom), T. Charalampopolous (Sheffield, United Kingdom), I. Sabroe (Sheffield, United Kingdom), K. Dwivedi (Sheffield, United Kingdom), S. Rajaram (Sheffield, United Kingdom), C. Hill (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom), R. Condliffe (Sheffield, United Kingdom), D. Kiely (Sheffield, United Kingdom)
| |
Sequential analysis of right ventricular function and exercise capacity in pulmonary arterial hypertension
T. Nakaya (Sapporo, Japan), T. Sato (Sapporo, Japan), T. Watanabe (Sapporo, Japan), H. Ohira (Sapporo, Japan), N. Oyama-Manabe (Sapporo, Japan), I. Tsujino (Sapporo, Japan)
| |
Dose-response relationship of oral treprostinil for secondary endpoints in the FREEDOM-EV study
R. White (Rochester, United States of America), E. Grünig (Heidelberg, Germany), C. Jerjes-Sanchez D (Monterrey, Mexico), G. Bohns Meyer (Porto Alegre, Brazil), T. Pulido (Mexico City, Mexico), P. Sepulveda (Santiago, Chile), K. Wang (Taichung, Taiwan), C. Deng (Research Triangle Park, United States of America), R. Grover (Research Triangle Park, United States of America), D. Solum (Research Triangle Park, United States of America), A. Ousmanou (Research Triangle Park, United States of America), V. Tapson (Los Angeles, United States of America)
| |
Long-term safety and outcome of subcutaneous and intravenous treprostinil in patients with severe chronic pulmonary hypertension
S. Harutyunova (Heidelberg, Germany), N. Benkamin (Heidelberg, Germany), C. Eichstaedt (Heidelberg, Germany), A. Marra (Heidelberg, Germany), P. Xanthouli (Heidelberg, Germany), B. Egenlauf (Heidelberg, Germany), E. Grünig (Heidelberg, Germany)
| |
Hemodynamic phenotypes in systemic sclerosis patients screened for pulmonary hypertension – impact of the new PH-definition
P. Xanthouli (Heidelberg, Germany), N. Milde (Heidelberg, Germany), V. Theobald (Heidelberg, Germany), A. Marra (Heidelberg, Germany), N. Benjamin (Heidelberg, Germany), C. Nagel (Heidelberg, Germany), C. Eichstaedt (Heidelberg, Germany), N. Blank (Heidelberg, Germany), B. Egenlauf (Heidelberg, Germany), S. Harutyunova (Heidelberg, Germany), H. Lorenz (Heidelberg, Germany), E. Grünig (Heidelberg, Germany)
| |
Factors associated with daily physical activity in patients with Pulmonary arterial hypertension.
L. Lima (Campinas, Brazil), F. Mendes (São Paulo, Brazil), M. Moreira (Campinas, Brazil), D. Oliveira (Campinas, Brazil), M. Pereira (Campinas, Brazil)
| |
Using Step Count to Enhance Daily Physical Activity in PH, a pilot-study (STEP in PH).
B. Vigo (Milan, Italy), R. Rinaldo (Milan, Italy), S. Job (Milan, Italy), F. Di Marco (Bergamo, Italy), L. Howard (London, United Kingdom)
| |
Therapeutic limitations of oral medications to normalize hemodynamics in patients with pulmonary artery hypertension.
H. Shimokawahara (Okayama city, Japan), H. Matsubara (Okayama city, Japan), K. Hayashi (Okayama city, Japan), T. Nishihara (Okayama city, Japan), M. Tsuji (Okayama city, Japan), T. Naito (Okayama city, Japan), M. Shigetoshi (Okayama city, Japan), I. Tabuchi (Okayama city, Japan), M. Munemasa (Okayama city, Japan)
| |
Characteristics of patients meeting the new definition of pulmonary hypertension (Nice 2018) in single Japanese PH center.
K. Yamamoto (Chiba, Japan), N. Tanabe (Chiba, Japan), R. Suda (Chiba, Japan), A. Naito (Chiba, Japan), A. Sekine (Chiba, Japan), R. Nishimura (Chiba, Japan), T. Jujo (Chiba, Japan), A. Shigeta (Chiba, Japan), S. Sakao (Chiba, Japan), K. Tatsumi (Chiba, Japan)
| |
6 minute walk work and other clinical correlates of peak VO2 in pulmonary vascular disease
L. Robertson (Cambridge, United Kingdom), K. Oates (Cambridge, United Kingdom), A. Fletcher (Cambridge, United Kingdom), K. Sylvester (Cambridge, United Kingdom)
| |
Correlation between perceived quality of life among patients with Pulmonary Arterial Hypertension, the 6-minute walking test and the risk stratification.
A. Martinez Meñaca (Santander, Spain), I. Fernandez-Cuesta Peñafiel (Madrid, Spain), I. Blanco Vich (Barcelona, Spain), A. Roman Broto (Barcelona, Spain), J. Cifrian Martinez (Santander, Spain), P. Escribano Subias (Madrid, Spain), P. Bedate Diaz (Oviedo, Spain)
| |
Right heart catheterization hemodynamics at rest and exercise in supine versus upright position with focus on pulmonary hypertension
C. Berlier (Zurich, Switzerland), P. Bader (Zurich, Switzerland), S. Saxer (Zurich, Switzerland), M. Lichtblau (Zurich, Switzerland), E. Hasler (Zurich, Switzerland), E. Schwarz (Zurich, Switzerland), M. Furian (Zurich, Switzerland), K. Bloch (Zurich, Switzerland), S. Ulrich (Zurich, Switzerland)
| |